By Professor Miles Davenport

Book Chapters

Hill AVS; Yates SNR; Allsopp CEM; Gupta S; Gilbert SC; Lalvani A; Aidoo M; Davenport M; Plebanski M, 1997, 'Human leukocyte antigens and natural selection by malaria', in Infection, Polymorphism and Evolution, Springer Netherlands, pp. 109 - 115, http://dx.doi.org/10.1007/978-94-009-0077-6_12

Davenport MP; Hill AVS, 1996, 'The MHC in Host-Pathogen Evolution', in MHC Molecules: Expression, Assembly and Function, Springer US, pp. 243 - 260, http://dx.doi.org/10.1007/978-1-4684-6462-7_15

Journal articles

Hastak P; Cromer D; Malycha J; Andersen CR; Raith E; Davenport MP; Plummer M; Sasson SC, 2024, 'Defining the correlates of lymphopenia and independent predictors of poor clinical outcome in adults hospitalized with COVID-19 in Australia', Scientific Reports, 14, http://dx.doi.org/10.1038/s41598-024-61729-5

Cromer D; Reynaldi A; Mitchell A; Schlub TE; Juno JA; Wheatley AK; Kent SJ; Khoury DS; Davenport MP, 2024, 'Predicting COVID-19 booster immunogenicity against future SARS-CoV-2 variants and the benefits of vaccine updates', Nature Communications, 15, http://dx.doi.org/10.1038/s41467-024-52194-9

Berry MT; Khan SR; Schlub TE; Notaras A; Kunasekaran M; Grulich AE; MacIntyre CR; Davenport MP; Khoury DS, 2024, 'Predicting vaccine effectiveness for mpox', Nature Communications, 15, pp. 3856, http://dx.doi.org/10.1038/s41467-024-48180-w

Kent SJ; Li S; Amarasena TH; Reynaldi A; Lee WS; Leeming MG; O’Connor DH; Nguyen J; Kent HE; Caruso F; Juno JA; Wheatley AK; Davenport MP; Ju Y, 2024, 'Blood Distribution of SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine in Humans', ACS Nano, 18, pp. 27077 - 27089, http://dx.doi.org/10.1021/acsnano.4c11652

Lee WS; Audsley J; Trieu MC; Reynaldi A; Aurelia LC; Mehta PH; Patterson J; Kent HE; Nguyen J; Amarasena T; Esterbauer R; Haycroft ER; Ramanathan P; Davenport MP; Schlub TE; Sasadeusz J; Wheatley AK; Chung AW; Juno JA; Selva KJ; Kent SJ, 2024, 'Randomized controlled trial reveals no benefit to a 3-month delay in COVID-19 mRNA booster vaccine', Journal of Clinical Investigation, 134, http://dx.doi.org/10.1172/JCI181244

Underwood AP; Gupta M; Wu BR; Eltahla AA; Boo I; Wang JJ; Agapiou D; Abayasingam A; Reynaldi A; Keoshkerian E; Zhao Y; Brasher N; Walker MR; Bukh J; Maher L; Gordon T; Davenport MP; Luciani F; Drummer HE; Lloyd AR; Bull RA, 2024, 'B-cell characteristics define HCV reinfection outcome', Journal of Hepatology, 81, pp. 415 - 428, http://dx.doi.org/10.1016/j.jhep.2024.04.004

Varco-Merth B; Chaunzwa M; Duell DM; Marenco A; Goodwin W; Dannay R; Nekorchuk M; Shao D; Busman-Sahay K; Fennessey CM; Silipino L; Hull M; Bosche WJ; Fast R; Oswald K; Shoemaker R; Bochart R; MacAllister R; Labriola CS; Smedley JV; Axthelm MK; Davenport MP; Edlefsen PT; Estes JD; Keele BF; Lifson JD; Lewin SR; Picker LJ; Okoye AA, 2024, 'Impact of alemtuzumab-mediated lymphocyte depletion on SIV reservoir establishment and persistence', PLoS Pathogens, 20, http://dx.doi.org/10.1371/journal.ppat.1012496

Elias KM; Khan SR; Stadler E; Schlub TE; Cromer D; Polizzotto MN; Kent SJ; Turner T; Davenport MP; Khoury DS, 2024, 'Viral clearance as a surrogate of clinical efficacy for COVID-19 therapies in outpatients: a systematic review and meta-analysis', The Lancet Microbe, 5, pp. e459 - e467, http://dx.doi.org/10.1016/S2666-5247(23)00398-1

Keele BF; Okoye AA; Fennessey CM; Varco-Merth B; Immonen TT; Kose E; Conchas A; Pinkevych M; Lipkey L; Newman L; MacAiran A; Bosche M; Bosche WJ; Berkemeier B; Fast R; Hull M; Oswald K; Shoemaker R; Silipino L; Gorelick RJ; Duell D; Marenco A; Brantley W; Smedley J; Axthelm M; Davenport MP; Lifson JD; Picker LJ, 2024, 'Early antiretroviral therapy in SIV-infected rhesus macaques reveals a multiphasic, saturable dynamic accumulation of the rebound competent viral reservoir', PLoS Pathogens, 20, http://dx.doi.org/10.1371/journal.ppat.1012135

Watson NB; Patel RK; Kean C; Veazey J; Oyesola OO; Laniewski N; Grenier JK; Wang J; Tabilas C; Yee Mon KJ; McNairn AJ; Peng SA; Wesnak SP; Nzingha K; Davenport MP; Tait Wojno ED; Scheible KM; Smith NL; Grimson A; Rudd BD, 2024, 'The gene regulatory basis of bystander activation in CD8⁺ T cells', Science Immunology, 9, http://dx.doi.org/10.1126/sciimmunol.adf8776

Wagstaffe HR; Thwaites RS; Reynaldi A; Sidhu JK; McKendry R; Ascough S; Papargyris L; Collins AM; Xu J; Lemm NM; Siggins MK; Chain BM; Killingley B; Kalinova M; Mann A; Catchpole A; Davenport MP; Openshaw PJM; Chiu C, 2024, 'Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults', Science Immunology, 9, http://dx.doi.org/10.1126/sciimmunol.adj9285

Purcell RA; Aurelia LC; Esterbauer R; Allen LF; Bond KA; Williamson DA; Trevillyan JM; Trubiano JA; Juno JJ; Wheatley AK; Davenport MP; Nguyen THO; Kedzierska K; Kent SJ; Selva KJ; Chung AW, 2024, 'Immunoglobulin G genetic variation can confound assessment of antibody levels via altered binding to detection reagents', Clinical and Translational Immunology, 13, http://dx.doi.org/10.1002/cti2.1494

Stadler E; Cromer D; Ogunlade S; Ongoiba A; Doumbo S; Kayentao K; Traore B; Crompton PD; Portugal S; Davenport MP; Khoury DS, 2023, 'Evidence for exposure dependent carriage of malaria parasites across the dry season: modelling analysis of longitudinal data', Malaria Journal, 22, http://dx.doi.org/10.1186/s12936-023-04461-1

Stadler E; Burgess MT; Schlub TE; Khan SR; Chai KL; McQuilten ZK; Wood EM; Polizzotto MN; Kent SJ; Cromer D; Davenport MP; Khoury DS, 2023, 'Monoclonal antibody levels and protection from COVID-19', Nature Communications, 14, pp. 4545, http://dx.doi.org/10.1038/s41467-023-40204-1

Cromer D; Steain M; Reynaldi A; Schlub TE; Khan SR; Sasson SC; Kent SJ; Khoury DS; Davenport MP, 2023, 'Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis', Nature Communications, 14, pp. 1633, http://dx.doi.org/10.1038/s41467-023-37176-7

Stadler E; Chai KL; Schlub TE; Cromer D; Khan SR; Polizzotto MN; Kent SJ; Beecher C; White H; Turner T; Skoetz N; Estcourt L; McQuilten ZK; Wood EM; Khoury DS; Davenport MP, 2023, 'Determinants of passive antibody efficacy in SARS-CoV-2 infection: a systematic review and meta-analysis', The Lancet Microbe, 4, pp. e883 - e892, http://dx.doi.org/10.1016/S2666-5247(23)00194-5

Selva KJ; Ramanathan P; Haycroft ER; Tan CW; Wang LF; Downie LE; Davis SK; Purcell RA; Kent HE; Juno JA; Wheatley AK; Davenport MP; Kent SJ; Chung AW, 2023, 'Mucosal antibody responses following Vaxzevria vaccination', Immunology and Cell Biology, 101, pp. 975 - 983, http://dx.doi.org/10.1111/imcb.12685

Docken SS; McCormick K; Pampena MB; Samer S; Lindemuth E; Pinkevych M; Viox EG; Wu Y; Schlub TE; Cromer D; Keele BF; Paiardini M; Betts MR; Bar KJ; Davenport MP, 2023, 'Preferential selection of viral escape mutants by CD8+ T cell 'sieving' of SIV reactivation from latency', PLoS Pathogens, 19, http://dx.doi.org/10.1371/journal.ppat.1011755

Pinkevych M; Docken SS; Okoye AA; Fennessey CM; Del Prete GQ; Pino M; Harper JL; Betts MR; Paiardini M; Keele BF; Davenport MP, 2023, 'Timing of initiation of anti-retroviral therapy predicts post-treatment control of SIV replication', PLoS Pathogens, 19, http://dx.doi.org/10.1371/journal.ppat.1011660

Lansink LIM; Skinner OP; Engel JA; Lee HJ; Soon MSF; Williams CG; SheelaNair A; Pernold CPS; Laohamonthonkul P; Akter J; Stoll T; Hill MM; Talman AM; Russell A; Lawniczak M; Jia X; Chua B; Anderson D; Creek DJ; Davenport MP; Khoury DS; Haque A, 2023, 'Systemic host inflammation induces stage-specific transcriptomic modification and slower maturation in malaria parasites', mBio, 14, pp. e0112923, http://dx.doi.org/10.1128/mbio.01129-23

Bauer A; Lindemuth E; Marino FE; Krause R; Joy J; Docken SS; Mallick S; McCormick K; Holt C; Georgiev I; Felber B; Keele BF; Veazey R; Davenport MP; Li H; Shaw GM; Bar KJ, 2023, 'Adaptation of a transmitted/founder simian-human immunodeficiency virus for enhanced replication in rhesus macaques', PLoS Pathogens, 19, http://dx.doi.org/10.1371/journal.ppat.1011059

Lee WS; Tan HX; Reynaldi A; Esterbauer R; Koutsakos M; Nguyen J; Amarasena T; Kent HE; Aggarwal A; Turville SG; Taiaroa G; Kinsella P; Liew KC; Tran T; Williamson DA; Cromer D; Davenport MP; Kent SJ; Juno JA; Khoury DS; Wheatley AK, 2023, 'Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infection', Science Advances, 9, http://dx.doi.org/10.1126/sciadv.adg5301

Zhang W; Kedzierski L; Chua BY; Mayo M; Lonzi C; Rigas V; Middleton BF; McQuilten HA; Rowntree LC; Allen LF; Purcell RA; Tan HX; Petersen J; Chaurasia P; Mordant F; Pogorelyy MV; Minervina AA; Crawford JC; Perkins GB; Zhang E; Gras S; Clemens EB; Juno JA; Audsley J; Khoury DS; Holmes NE; Thevarajan I; Subbarao K; Krammer F; Cheng AC; Davenport MP; Grubor-Bauk B; Coates PT; Christensen B; Thomas PG; Wheatley AK; Kent SJ; Rossjohn J; Chung AW; Boffa J; Miller A; Lynar S; Nelson J; Nguyen THO; Davies J; Kedzierska K, 2023, 'Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities', Nature Immunology, 24, pp. 966 - 978, http://dx.doi.org/10.1038/s41590-023-01508-y

Koutsakos M; Reynaldi A; Lee WS; Nguyen J; Amarasena T; Taiaroa G; Kinsella P; Liew KC; Tran T; Kent HE; Tan HX; Rowntree LC; Nguyen THO; Thomas PG; Kedzierska K; Petersen J; Rossjohn J; Williamson DA; Khoury D; Davenport MP; Kent SJ; Wheatley AK; Juno JA, 2023, 'SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses', Immunity, 56, pp. 879 - 892.e4, http://dx.doi.org/10.1016/j.immuni.2023.02.017

Khoury DS; Docken SS; Subbarao K; Kent SJ; Davenport MP; Cromer D, 2023, 'Predicting the efficacy of variant-modified COVID-19 vaccine boosters', Nature Medicine, 29, pp. 574 - 578, http://dx.doi.org/10.1038/s41591-023-02228-4

Khoury DS; Schlub TE; Cromer D; Steain M; Fong Y; Gilbert PB; Subbarao K; Triccas JA; Kent SJ; Davenport MP, 2023, 'Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 Infection', Emerging Infectious Diseases, 29, pp. 381 - 388, http://dx.doi.org/10.3201/eid2902.221422

Statzu M; Jin W; Fray EJ; Wong AKH; Kumar MR; Ferrer E; Docken SS; Pinkevych M; McBrien JB; Fennessey CM; Keele BF; Liang S; Harper JL; Mutascio S; Franchitti L; Wang H; Cicetti D; Bosinger SE; Carnathan DG; Vanderford TH; Margolis DM; Garcia-Martinez JV; Chahroudi A; Paiardini M; Siliciano J; Davenport MP; Kulpa DA; Siliciano RS; Silvestri G, 2023, 'CD8+ lymphocytes do not impact SIV reservoir establishment under ART', Nature Microbiology, 8, pp. 299 - 308, http://dx.doi.org/10.1038/s41564-022-01311-9

Habel JR; Chua BY; Kedzierski L; Selva KJ; Damelang T; Haycroft ER; Nguyen THO; Koay HF; Nicholson S; McQuilten HA; Jia X; Allen LF; Hensen L; Zhang W; van de Sandt CE; Neil JA; Pragastis K; Lau JSY; Jumarang J; Allen EK; Amanant F; Krammer F; Wragg KM; Juno JA; Wheatley AK; Tan HX; Pell G; Walker S; Audsley J; Reynaldi A; Thevarajan I; Denholm JT; Subbarao K; Davenport MP; Hogarth PM; Godfrey DI; Cheng AC; Tong SYC; Bond K; Williamson DA; McMahon JH; Thomas PG; Pannaraj PS; James F; Holmes NE; Smibert OC; Trubiano JA; Gordon CL; Chung AW; Whitehead CL; Kent SJ; Lappas M; Rowntree LC; Kedzierska K, 2023, 'Immune profiling of SARS-CoV-2 infection during pregnancy reveals NK cell and γδ T cell perturbations', JCI Insight, 8, http://dx.doi.org/10.1172/jci.insight.167157

Selva KJ; Ramanathan P; Haycroft ER; Reynaldi A; Cromer D; Tan CW; Wang LF; Wines BD; Hogarth PM; Downie LE; Davis SK; Purcell RA; Kent HE; Juno JA; Wheatley AK; Davenport MP; Kent SJ; Chung AW, 2023, 'Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infections', JCI Insight, 8, http://dx.doi.org/10.1172/jci.insight.172470

Underwood AP; Gupta M; Wu B-R; Eltahla AA; Boo I; Wang JJ; Agapiou D; Abayasingam A; Reynaldi A; Keoshkerian E; Zhao Y; Brasher N; Walker MR; Bukh J; Maher L; Gordon T; Davenport M; Luciani F; Drummer HE; Lloyd AR; Bull RA, 2023, 'B Cell Signatures and Antibody Imprinting Define HCV Reinfection Outcome', , http://dx.doi.org/10.2139/ssrn.4418620

Tabilas C; Iu DS; Daly CWP; Yee Mon KJ; Reynaldi A; Wesnak SP; Grenier JK; Davenport MP; Smith NL; Grimson A; Rudd BD, 2022, 'Early microbial exposure shapes adult immunity by altering CD8+ T cell development', Proceedings of the National Academy of Sciences of the United States of America, 119, http://dx.doi.org/10.1073/pnas.2212548119

Stadler E; Cromer D; Mehra S; Adekunle AI; Flegg JA; Anstey NM; Watson JA; Chu CS; Mueller I; Robinson LJ; Schlub TE; Davenport MP; Khoury DS, 2022, 'Population heterogeneity in Plasmodium vivax relapse risk', PLoS Neglected Tropical Diseases, 16, http://dx.doi.org/10.1371/journal.pntd.0010990

SheelaNair A; Romanczuk AS; Aogo RA; Haldar RN; Lansink LIM; Cromer D; Salinas YG; Guy RK; McCarthy JS; Davenport MP; Haque A; Khoury DS, 2022, 'Similarly efficacious anti-malarial drugs SJ733 and pyronaridine differ in their ability to remove circulating parasites in mice', Malaria Journal, 21, http://dx.doi.org/10.1186/s12936-022-04075-z

Tan HX; Davenport MP; Kent SJ; Wheatley AK, 2022, 'Nice and slow make the germinal centers go: measured and escalating antigen delivery enhance durability and quality of humoral immune responses against HIV-1', Immunology and Cell Biology, 100, pp. 750 - 752, http://dx.doi.org/10.1111/imcb.12596

Koutsakos M; Lee WS; Reynaldi A; Tan HX; Gare G; Kinsella P; Liew KC; Taiaroa G; Williamson DA; Kent HE; Stadler E; Cromer D; Khoury DS; Wheatley AK; Juno JA; Davenport MP; Kent SJ, 2022, 'The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants', Immunity, 55, pp. 1316 - 1326.e4, http://dx.doi.org/10.1016/j.immuni.2022.05.018

Radohery GFR; Walz A; Gumpp C; Cherkaoui-Rbati MH; Gobeau N; Gower J; Davenport MP; Rottmann M; McCarthy JS; Möhrle JJ; Rebelo M; Demarta-Gatsi C; Khoury DS, 2022, 'Parasite Viability as a Measure of in Vivo Drug Activity in Preclinical and Early Clinical Antimalarial Drug Assessment', Antimicrobial Agents and Chemotherapy, 66, http://dx.doi.org/10.1128/aac.00114-22

Cromer D; Reynaldi A; Steain M; Triccas JA; Davenport MP; Khoury DS, 2022, 'Relating in Vitro Neutralization Level and Protection in the CVnCoV (CUREVAC) Trial', Clinical Infectious Diseases, 75, pp. E878 - E879, http://dx.doi.org/10.1093/cid/ciac075

Kent SJ; Khoury DS; Reynaldi A; Juno JA; Wheatley AK; Stadler E; John Wherry E; Triccas J; Sasson SC; Cromer D; Davenport MP, 2022, 'Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?', Nature Reviews Immunology, 22, pp. 387 - 397, http://dx.doi.org/10.1038/s41577-022-00716-1

Radohery GFR; Gower J; Barber BE; Kansagra K; Möhrle JJ; Davenport MP; McCarthy JS; Khoury DS; Rebelo M, 2022, 'Effect of novel antimalarial ZY-19489 on Plasmodium falciparum viability in a volunteer infection study', The Lancet Infectious Diseases, 22, pp. 760 - 761, http://dx.doi.org/10.1016/S1473-3099(22)00294-8

Aggarwal A; Stella AO; Walker G; Akerman A; Esneau C; Milogiannakis V; Burnett DL; McAllery S; Silva MR; Lu Y; Foster CSP; Brilot F; Pillay A; Van Hal S; Mathivanan V; Fichter C; Kindinger A; Hoppe AC; Munier ML; Amatayakul-Chantler S; Roth N; Coppola G; Symonds GP; Schofield P; Jackson J; Lenthall H; Henry JY; Mazigi O; Jäck HM; Davenport MP; Darley DR; Matthews GV; Khoury DS; Cromer D; Goodnow CC; Christ D; Robosa R; Starck DJ; Bartlett NW; Rawlinson WD; Kelleher AD; Turville SG, 2022, 'Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia', Nature Microbiology, 7, pp. 896 - 908, http://dx.doi.org/10.1038/s41564-022-01135-7

Goel RR; Painter MM; Lundgreen KA; Apostolidis SA; Baxter AE; Giles JR; Mathew D; Pattekar A; Reynaldi A; Khoury DS; Gouma S; Hicks P; Dysinger S; Hicks A; Sharma H; Herring S; Korte S; KC W; Oldridge DA; Erickson RI; Weirick ME; McAllister CM; Awofolaju M; Tanenbaum N; Dougherty J; Long S; D'Andrea K; Hamilton JT; McLaughlin M; Williams JC; Adamski S; Kuthuru O; Drapeau EM; Davenport MP; Hensley SE; Bates P; Greenplate AR; Wherry EJ, 2022, 'Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine', Cell, 185, pp. 1875 - 1887.e8, http://dx.doi.org/10.1016/j.cell.2022.04.009

Stern J; Solomon A; Dantanarayana A; Pascoe R; Reynaldi A; Davenport MP; Milush J; Deeks SG; Hartogensis W; Hecht FM; Cockerham L; Roche M; Lewin SR, 2022, 'Cell-Associated Human Immunodeficiency Virus (HIV) Ribonucleic Acid Has a Circadian Cycle in Males With HIV on Antiretroviral Therapy', Journal of Infectious Diseases, 225, pp. 1721 - 1730, http://dx.doi.org/10.1093/infdis/jiab533

Wragg KM; Lee WS; Koutsakos M; Tan HX; Amarasena T; Reynaldi A; Gare G; Konstandopoulos P; Field KR; Esterbauer R; Kent HE; Davenport MP; Wheatley AK; Kent SJ; Juno JA, 2022, 'Establishment and recall of SARS-CoV-2 spike epitope-specific CD4⁺ T cell memory', Nature Immunology, 23, pp. 768 - 780, http://dx.doi.org/10.1038/s41590-022-01175-5

Habel JR; Chua BY; Kedzierski L; Selva KJ; Damelang T; Haycroft ER; Nguyen THO; Koay H-F; Nicholson S; McQuilten H; Jia X; Allen LF; Hensen L; Zhang W; van de Sandt CE; Neil JA; Amanant F; Krammer F; Wragg K; Juno JA; Wheatley AK; Tan H-X; Pell G; Audsley J; Reynaldi A; Thevarajan I; Denholm J; Subbarao K; Davenport MP; Hogarth M; Godrey DI; Cheng AC; Tong SYC; Bond K; Williamson DA; James F; Holmes NE; Smibert OC; Trubiano JA; Gordon CL; Chung AW; Whitehead C; Kent SJ; Lappas M; Rowntree LC; Kedzierska K, 2022, 'Integrated immune networks in SARS-CoV-2 infected pregnant women reveal differential NK cell and unconventional T cell activation', The Journal of Immunology, 208, pp. 125.10 - 125.10, http://dx.doi.org/10.4049/jimmunol.208.supp.125.10

Cele S; Jackson L; Khoury DS; Khan K; Moyo-Gwete T; Tegally H; San JE; Cromer D; Scheepers C; Amoako DG; Karim F; Bernstein M; Lustig G; Archary D; Smith M; Ganga Y; Jule Z; Reedoy K; Hwa SH; Giandhari J; Blackburn JM; Gosnell BI; Abdool Karim SS; Hanekom W; Davies MA; Hsiao M; Martin D; Mlisana K; Wibmer CK; Williamson C; York D; Harrichandparsad R; Herbst K; Jeena P; Khoza T; Kløverpris H; Leslie A; Madansein R; Magula N; Manickchund N; Marakalala M; Mazibuko M; Moshabela M; Mthabela N; Naidoo K; Ndhlovu Z; Ndung’u T; Ngcobo N; Nyamande K; Patel V; Smit T; Steyn A; Wong E; von Gottberg A; Bhiman JN; Lessells RJ; Moosa MYS; Davenport MP; de Oliveira T; Moore PL; Sigal A, 2022, 'Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization', Nature, 602, pp. 654 - 656, http://dx.doi.org/10.1038/s41586-021-04387-1

Cromer D; Steain M; Reynaldi A; Schlub TE; Wheatley AK; Juno JA; Kent SJ; Triccas JA; Khoury DS; Davenport MP, 2022, 'Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis', The Lancet Microbe, 3, pp. e52 - e61, http://dx.doi.org/10.1016/S2666-5247(21)00267-6

Goel RR; Painter MM; Apostolidis SA; Mathew D; Meng W; Rosenfeld AM; Lundgreen KA; Reynaldi A; Khoury DS; Pattekar A; Gouma S; Kuri-Cervantes L; Hicks P; Dysinger S; Hicks A; Sharma H; Herring S; Korte S; Baxter AE; Oldridge DA; Giles JR; Weirick ME; McAllister CM; Awofolaju M; Tanenbaum N; Drapeau EM; Dougherty J; Long S; D’Andrea K; Hamilton JT; McLaughlin M; Williams JC; Adamski S; Kuthuru O; Frank I; Betts MR; Vella LA; Grifoni A; Weiskopf D; Sette A; Hensley SE; Davenport MP; Bates P; Luning Prak ET; Greenplate AR; John Wherry E, 2021, 'mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern', Science, 374, http://dx.doi.org/10.1126/science.abm0829

Wheatley AK; Juno JA; Wang JJ; Selva KJ; Reynaldi A; Tan HX; Lee WS; Wragg KM; Kelly HG; Esterbauer R; Davis SK; Kent HE; Mordant FL; Schlub TE; Gordon DL; Khoury DS; Subbarao K; Cromer D; Gordon TP; Chung AW; Davenport MP; Kent SJ, 2021, 'Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19', Nature Communications, 12, http://dx.doi.org/10.1038/s41467-021-21444-5

Back to profile page